Diagnosis of Brugada Syndrome With a Sodium-Channel-Blocker Test: Who Should Be Tested? Who Should Not?
S Viskin, E Chorin, R Rosso, AS Amin, AA Wilde - Circulation, 2024 - ahajournals.org
Intravenous infusion of sodium-channel blockers (SCB) with either ajmaline, flecainide,
procainamide, or pilsicainide to unmask the ECG of Brugada syndrome is the drug …
procainamide, or pilsicainide to unmask the ECG of Brugada syndrome is the drug …
Arrhythmia detection using an implantable loop recorder after a negative electrophysiology study in Brugada syndrome: Observations from a multicenter international …
E García-Izquierdo, C Scrocco, J Palacios-Rubio… - Heart Rhythm, 2024 - Elsevier
Abstract Background Risk stratification in Brugada syndrome (BrS) remains controversial. In
this respect, the role of the electrophysiology study (EPS) has been a subject of debate. In …
this respect, the role of the electrophysiology study (EPS) has been a subject of debate. In …
AI in Predictive Toxicology
B Yingngam - AI-Powered Advances in Pharmacology, 2025 - igi-global.com
The field of toxicology is undergoing a significant transformation due to the integration of
artificial intelligence (AI). In addition to traditional reliance on empirical studies and animal …
artificial intelligence (AI). In addition to traditional reliance on empirical studies and animal …
[HTML][HTML] A Case Report of Brugada Syndrome Associated With Physical Trauma
D Nirmal, N Stojanovic, A Kishore, S Sivakumar… - Cureus, 2024 - ncbi.nlm.nih.gov
Brugada syndrome is an autosomal dominant channelopathy that usually affects healthy
young males without apparent structural heart disease. It is associated with a spectrum of …
young males without apparent structural heart disease. It is associated with a spectrum of …